For decades, scientists had been searching for a vaccine that could fend off RSV and reduce the chance of extreme illness. A breakthrough finally came in 2013 when researchers identified a protein ...

Experts worry that the unenthusiastic embrace of vaccines could spark outbreaks and increased hospitalizations.

COVID-19, influenza, and respiratory syncytial virus (RSV) vaccination coverage is low among adults so far this respiratory ...

COVID-19, influenza, and respiratory syncytial virus (RSV) vaccination coverage is low among nursing home residents e ...

Respiratory syncytial virus, or RSV, is something many parents know as a cause of bronchiolitis, but others may not have ...

RSV is the most common cause of hospitalization in infants under 1 year old. The infection can spread to the lungs and cause ...

COVID-19 and respiratory syncytial virus (RSV) vaccines this fall in older adults. Uptake was lowest among younger adults and in people who didn’t have health insurance, the data showed.

As of this month, about 37 percent of adults 18 and older had received a seasonal flu shot, while 19 percent had received ...

As of March, 41 percent of eligible infants had received the RSV antibody treatment. Some of the hesitancy toward vaccines can be attributed to a swarm of misinformation on social media and the ...

Respiratory syncytial virus, or RSV, is something many parents know as a cause of bronchiolitis, but others may not have heard of it until recently. RSV causes infections of the lungs and ...

with an increased risk for severe RSV had ever received an RSV vaccine. There was variation seen in coverage by jurisdiction and demographic characteristics, with younger adults and those without ...